United States · FDA National Drug Code directory

Sumatriptan and Naproxen Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 47335-410_c67d3234-28c7-40a9-a472-87747bb4242a
Product NDC: 47335-410
Form: TABLET, FILM COATED
Composition / generic term: Sumatriptan and Naproxen Sodium
Labeler: Sun Pharmaceutical Industries, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20180720
Source listing expiry: 20261231

Source-listed ingredients

SUMATRIPTAN SUCCINATE — 85 mg/1
NAPROXEN SODIUM — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

9 TABLET, FILM COATED in 1 BOTTLE (47335-410-22) · 47335-410-22
30 TABLET, FILM COATED in 1 BOTTLE (47335-410-83) · 47335-410-83
100 TABLET, FILM COATED in 1 BOTTLE (47335-410-88) · 47335-410-88

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →